Fidelis Capital Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,061
Closed -$235K – 555
2026
Q1
$235K Buy
1,061
+13
+1% +$3.18K 0.02% 454
2025
Q4
$266K Buy
1,048
+8
+0.8% +$2.01K 0.02% 407
2025
Q3
$257K Buy
1,040
+10
+1% +$2.39K 0.02% 410
2025
Q2
$228K Buy
1,030
+29
+3% +$6.75K 0.02% 399
2025
Q1
$225K Sell
1,001
-31
-3% -$6.82K 0.02% 387
2024
Q4
$225K Buy
1,032
+84
+9% +$18.4K 0.02% 392
2024
Q3
$210K Sell
948
-2
-0.2% -$468 0.03% 392
2024
Q2
$222K Buy
950
+29
+3% +$6.3K 0.03% 337
2024
Q1
$207K Buy
+921
New +$208K 0.03% 349

Other funds holding STE

Fidelis Capital Partners's STE Position: Q2 2026 in Review

Fidelis Capital Partners sold out of Steris (STE) in Q2 2026, closing a stake of 1,061 shares — an estimated $235K sold.

Fidelis Capital Partners first reported a position in STE in Q1 2024 and held it in 9 quarters. The position peaked at $266K in Q4 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Fidelis Capital Partners reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
  • Fidelis Capital Partners sold 1,061 Steris shares in Q2 2026, an estimated $235K.
  • Fidelis Capital Partners first reported a position in Steris in Q1 2024 and held it in 9 quarters.
  • Fidelis Capital Partners's Steris position peaked at $266K in Q4 2025.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.